Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

New Technology Update

28 Nov 2018 07:00

RNS Number : 6896I
Plant Health Care PLC
28 November 2018
 

28 November 2018

 

PLANT HEALTH CARE plc

 

 

("Plant Health Care" or the "Company")

 

 

New Technology Update 

 

 

Plant Health Care®, a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to provide the following update in relation to its New Technology business in corn and soy crops.

 

Highlights:

- Plant Health Care's novel PREtec (Plant Response Elicitor Technology) has very large potential in the more than 375 million acres of corn and soy planted in North America, Brazil and Argentina.

- Three more global agricultural/seed companies have signed agreements to evaluate Plant Health Care's PREtec product candidates on multiple crops on three continents.

- These new collaborators are seeking novel, low toxicity biological products such as PREtec, to enable farmers to be more productive with lower environmental impact.

- Plant Health Care is continuing field trials with the Company's Innatus 3G peptide PHC279 against Asian Soybean Rust (ASR) in Brazil.

 

PREtec is a novel, environmentally friendly approach to protecting crops, based on peptides derived from natural proteins. These proprietary peptides are stable and compatible with mainstream agriculture practices. By activating the innate growth and defence mechanisms of plants, PREtec peptides lead to higher crop yields and better protection against disease and environmental stresses such as drought.

 

Corn and soy are major targets for PREtec. They are grown on more than 375 million acres in North and South America. A yield increase of just 2% brings a soybean farmer in Brazil almost an additional $10 per acre; in the USA it brings a corn (maize) farmer almost $13 per acre. Plant Health Care's evaluation partners supply most of the leading corn and soy seed treatments.

 

PREtec peptides can also reduce the corn yield losses caused by drought stress during critical growth stages. Under the drought conditions of the Company's field trials, corn plants whose seeds were treated with PREtec increased yield by an average of almost 17% over three consecutive growing seasons compared to untreated plants.

 

Three additional global agricultural companies have now signed agreements to evaluate several platforms of the PREtec technology. These companies join existing evaluation partners, who are looking for novel technology that will boost yield in row crops and have a safe environmental profile while solving significant problems faced by growers today.

 

In the 2018/19 soybean growing season in Brazil, Plant Health Care will be conducting further trials of PHC279 against Asian Soybean Rust (ASR). Last season this product did not deliver a decisive impact on disease symptoms as a foliar spray, but did show yield improvements. This season, trials will assess the economic value of PHC279 seed treatment and early season sprays.

 

Chris Richards, Executive Chairman & Interim CEO, said "As we continue to generate positive results from our PREtec platform of peptides, we are delighted to expand our range of partners who will evaluate our technology on multiple crops in multiple regions during the 2019 growing season."

 

For further information, please contact:

 

Plant Health Care plc

 

Chris Richards, Executive Chairman and Interim CEO

 

Tel: +1 919 926 1600

Arden Partners plc (Nomad and Broker)

John Llewellyn-Lloyd

 

Dan Gee-Summons

Tel: +44 (0) 20 7614 5900

 

IFC Advisory (Financial PR)

 

Graham Herring

 

Miles Nolan

 

Zach Cohen

Tel: +44 (0) 20 3934 6630

 

 

 

Company website: www.planthealthcare.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDPGGCGGUPRGBM
Date   Source Headline
14th Sep 20157:00 amRNSHalf Yearly Report
19th Aug 20157:00 amRNSBlocklisting Interim Review
13th Jul 20157:00 amRNSPHC Granted Product Registration in Brazil
18th Jun 20157:00 amRNSDirector/PDMR Shareholding
17th Jun 20152:20 pmRNSResult of AGM
2nd Jun 20157:00 amRNSRe Agreement
6th May 20157:01 amRNSPlant Health Care Hires Jeff Tweedy
30th Apr 20153:02 pmRNSTotal Voting Rights
22nd Apr 20153:05 pmRNSTR1: Notificiation of Major Interest in Shares
17th Apr 20157:00 amRNSDIRECTORS' DEALING
15th Apr 20157:00 amRNSAnnual Report 2014 and Notice of AGM
8th Apr 20157:00 amRNSRe Agreement
30th Mar 20157:00 amRNSAnnual Financial Report
27th Mar 20157:00 amRNSDirectorate Change
5th Mar 201512:30 pmRNSPlant Health Care signs Distribution Agreement
20th Feb 20155:48 pmRNSBlocklisting Interim Review
17th Feb 20154:03 pmRNSHolding(s) in Company
30th Jan 20157:00 amRNSBoard changes and trading update
15th Dec 20141:51 pmRNSTR-1: Notification of Major Interest in Shares
5th Dec 20147:00 amRNSPHC Signs Agreement With Arysta LifeScience
19th Nov 20147:00 amRNSPlant Health Care Hires LHA
11th Nov 20144:05 pmRNSHolding(s) in Company
30th Oct 20147:00 amRNSPHC & Sipcam Enter Agreement
27th Oct 20147:00 amRNS3G Peptide Technology Platform shows major promise
23rd Oct 20144:29 pmRNSHolding(s) in Company
6th Oct 201411:25 amRNSDirector/PDMR Shareholding
2nd Oct 20147:00 amRNSDirector/PDMR Shareholding
15th Sep 20147:00 amRNSHalf Yearly Report
19th Aug 201410:28 amRNSAIM Blocklisting Return
12th Aug 20143:10 pmRNSTR-1 Notification of Major Interest in Shares
22nd Jul 20144:10 pmRNSTR-1 Notification of Major Interest in Shares
30th Jun 20149:18 amRNSTotal Voting Rights
5th Jun 201412:45 pmRNSTR-1 Notification of Major Interest in Shares
22nd May 20147:00 amRNSDelisting of shares from the CISX
8th May 20141:30 pmRNSAGM Voting Results
15th Apr 201411:30 amRNSDirector/PDMR Shareholding
15th Apr 20147:00 amRNSDirector/PDMR Shareholding
9th Apr 20142:15 pmRNSDirector's Dealing - Grant of Share Options
9th Apr 20142:00 pmRNSTR-1 Notification of Major Interest in Shares
7th Apr 20145:15 pmRNSPublication of Annual Report 2013 & Notice of AGM
31st Mar 20143:45 pmRNSTotal Voting Rights
24th Mar 20147:00 amRNSPreliminary Results
3rd Mar 20144:35 pmRNSPrice Monitoring Extension
28th Feb 20141:00 pmRNSTotal Voting Rights
19th Feb 201412:15 pmRNSBlocklisting Interim Review
17th Feb 20149:45 amRNSTR-1 Notification of Major Interest in Shares
6th Feb 20144:40 pmRNSSecond Price Monitoring Extn
6th Feb 20144:35 pmRNSPrice Monitoring Extension
31st Jan 20143:00 pmRNSTotal Voting Rights
15th Jan 20147:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.